CN103467425A - Method for separating quercetin from oxytropis glabra - Google Patents
Method for separating quercetin from oxytropis glabra Download PDFInfo
- Publication number
- CN103467425A CN103467425A CN2013104038677A CN201310403867A CN103467425A CN 103467425 A CN103467425 A CN 103467425A CN 2013104038677 A CN2013104038677 A CN 2013104038677A CN 201310403867 A CN201310403867 A CN 201310403867A CN 103467425 A CN103467425 A CN 103467425A
- Authority
- CN
- China
- Prior art keywords
- quercetin
- deionized water
- glabrous crazyweed
- oxytropis
- volume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 title claims abstract description 95
- 235000005875 quercetin Nutrition 0.000 title claims abstract description 48
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 title claims abstract description 47
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 title claims abstract description 47
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 title claims abstract description 47
- 229960001285 quercetin Drugs 0.000 title claims abstract description 47
- 238000000034 method Methods 0.000 title claims abstract description 20
- 241000220099 Oxytropis glabra Species 0.000 title abstract description 6
- 239000011347 resin Substances 0.000 claims abstract description 13
- 229920005989 resin Polymers 0.000 claims abstract description 13
- 238000001179 sorption measurement Methods 0.000 claims abstract description 9
- 229930003944 flavone Natural products 0.000 claims abstract 3
- 150000002213 flavones Chemical class 0.000 claims abstract 3
- 235000011949 flavones Nutrition 0.000 claims abstract 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 239000008367 deionised water Substances 0.000 claims description 12
- 229910021641 deionized water Inorganic materials 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 238000004587 chromatography analysis Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000002137 ultrasound extraction Methods 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 238000001953 recrystallisation Methods 0.000 claims description 2
- 241000293302 Astragalus mollissimus Species 0.000 claims 10
- 239000012043 crude product Substances 0.000 claims 2
- 239000003463 adsorbent Substances 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 5
- 238000005903 acid hydrolysis reaction Methods 0.000 abstract 1
- 241001053158 Oxytropis Species 0.000 description 21
- 238000012360 testing method Methods 0.000 description 8
- 229930003935 flavonoid Natural products 0.000 description 7
- 150000002215 flavonoids Chemical class 0.000 description 7
- 235000017173 flavonoids Nutrition 0.000 description 7
- 230000007062 hydrolysis Effects 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- MORXWKWPBZJOQW-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one Chemical group C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1.C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 MORXWKWPBZJOQW-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 241001469664 Oxytropis floribunda Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- AUALQMFGWLZREY-UHFFFAOYSA-N acetonitrile;methanol Chemical group OC.CC#N AUALQMFGWLZREY-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical group CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- -1 quercetin flavonoids Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
技术领域technical field
本发明属于医药和保健品技术领域,涉及一种从小花棘豆中分离槲皮素的方法。The invention belongs to the technical field of medicine and health products, and relates to a method for isolating quercetin from Oxytropis chinensis.
背景技术Background technique
小花棘豆(Oxytropis glabra DC)是豆科(Leguminosae)棘豆属(Oxytropis)植物,在新疆分布广泛。据蒙药典记载,小花棘豆是一种重要的中蒙药原料,具有麻醉、镇静和止痛作用,主治牙痛、关节痛、失眠、健忘、神经衰弱及皮肤瘙痒。如小花棘豆4.5g、北五加皮6g及地枸叶9g,水煎服,可治关节痛。Oxytropis glabra DC is a plant belonging to the Leguminosae genus Oxytropis, widely distributed in Xinjiang. According to the Mongolian Pharmacopoeia, Oxytropis florida is an important raw material of Chinese and Mongolian medicines. It has anesthesia, sedative and analgesic effects, and is mainly used for toothache, joint pain, insomnia, forgetfulness, neurasthenia and skin itching. Such as Oxytropis floret 4.5g, Acanthopanax bark 6g and Lycium barbadensis 9g, decocted in water, can cure joint pain.
黄酮类化合物是小花棘豆的有效成分之一,其中含有槲皮素。槲皮素(quercetin),化学名为3,3′,4′,5,7-五羟基黄酮(3,3′,4′,5,7-pentahydroxyflavone),又名栎精、槲皮黄素,可作为药品。具有较好的祛痰、止咳作用,并有一定的平喘作用。此外还有抗氧化和清除自由基、保护心血管、预防冠心病、防治心肌缺血再灌注损伤、消炎,抗过敏,抗病毒和镇定、抗肿瘤、预防癌症等作用。可用于治疗慢性支气管炎,对冠心病和高血压患者也有辅助治疗作用。到目前为止,并未有小花棘豆中分离槲皮素的专利申请。Flavonoids are one of the active ingredients in Oxytropis floribunda, which contains quercetin. Quercetin (quercetin), the chemical name is 3,3',4',5,7-pentahydroxyflavone (3,3',4',5,7-pentahydroxyflavone), also known as quercetin, quercetin, Can be used as medicine. It has good expectorant and cough-relieving effects, and has a certain anti-asthma effect. In addition, it has anti-oxidation and free radical scavenging, cardiovascular protection, coronary heart disease prevention, myocardial ischemia-reperfusion injury prevention, anti-inflammation, anti-allergy, anti-virus and sedation, anti-tumor, and cancer prevention. It can be used to treat chronic bronchitis, and also has an auxiliary therapeutic effect on patients with coronary heart disease and hypertension. So far, there is no patent application for the isolation of quercetin from Oxytropis floret.
发明内容Contents of the invention
本发明的目的在于克服上述技术存在的缺陷,提供一种从小花棘豆中分离槲皮素的方法及应用,该方法利于操作、产品纯度高。The purpose of the present invention is to overcome the defects of the above-mentioned technology, and provide a method and application for isolating quercetin from Oxytropis florida, which is convenient for operation and has high product purity.
其具体技术方案为:Its specific technical plan is:
一种从小花棘豆中分离槲皮素的方法,包括以下步骤:A method for isolating quercetin from Oxytropis chinensis, comprising the following steps:
(1)小花棘豆粉碎:取小花棘豆地上部分,阴干、粉碎、过20目筛后备用;(1) Grinding of Oxytropis florida: Take the above-ground part of Oxytropis florida, dry in the shade, crush, pass through a 20-mesh sieve, and set aside;
(2)超声波协助法提取小花棘豆总提取物:称取小花棘豆样品,按照物料比1:15g/mL的比例加入体积分数100%的甲醇超声波提取90min,超声波功率800W,温度45℃,提取完成后过滤,滤液采用旋转蒸发仪浓缩,恒温干燥箱干燥,即得到小花棘豆总提取物;(2) Ultrasonic-assisted extraction of the total extract of Oxytropis florida: Weigh the sample of Oxytropis florida, add methanol with a volume fraction of 100% according to the ratio of material ratio 1:15g/mL, and ultrasonically extract for 90min, ultrasonic power 800W, temperature 45°C, After the extraction is completed, filter, the filtrate is concentrated by a rotary evaporator, and dried in a constant temperature drying oven to obtain the total extract of Oxytropis florida;
(3)小花棘豆黄酮的分离:将小花棘豆总提取物用水充分溶解;向层析柱中加入1/3体积的去离子水,然后将D-101型大孔吸附树脂用去离子水转移至层析柱中,加入70%的乙醇溶液,体积为树脂体积的2倍,流速为1倍树脂体积/min,然后用去离子水洗至无醇味后进行小花棘豆总提取物水溶液的梯度洗脱;大孔树脂最佳吸附工艺条件为:pH值4.0,温度室温,流速1.0BV/h;用10%~100%的乙醇洗脱,收集50%~85%的乙醇洗脱液,经旋转蒸发仪浓缩,冷冻干燥仪干燥,得到棕黄色粉末;(3) Separation of Oxytropis flavonoids: fully dissolve the total extract of Oxytropis florida with water; add 1/3 volume of deionized water to the chromatography column, and then deionize the D-101 macroporous adsorption resin with deionized water Transfer to a chromatographic column, add 70% ethanol solution, the volume is twice the volume of the resin, and the flow rate is 1 times the volume of the resin/min, then wash with deionized water until there is no alcohol smell, and then carry out the aqueous solution of the total extract of Oxytropis florida Gradient elution; the best adsorption process conditions for macroporous resin are: pH value 4.0, temperature at room temperature, flow rate 1.0BV/h; elute with 10% to 100% ethanol, collect 50% to 85% ethanol eluate, Concentrated by a rotary evaporator and dried by a freeze dryer to obtain a brown-yellow powder;
(4)槲皮素粗品的分离:称取小花棘豆黄酮约1.0g,加入体积比为V甲醇:V水:V盐酸=35:5:10的水解液60mL,于80℃水浴加热90min,冷却后过滤,60℃烘干即得黄色针状槲皮素粗产品;(4) Separation of crude quercetin: Weigh about 1.0 g of echinoclavone florets, add 60 mL of hydrolyzate with a volume ratio of V methanol : V water : V hydrochloric acid = 35:5:10, and heat in a water bath at 80°C for 90 minutes. After cooling, filter and dry at 60°C to obtain the crude quercetin product in the form of yellow needles;
(5)槲皮素的重结晶:取步骤(4)制备的槲皮素粗品约1.0g,加入100mL石油醚和20mL去离子水,于80℃加热搅拌30min,趁热过滤,用20mL去离子水洗涤沉淀3次,于60℃烘干得到槲皮素;称取槲皮素(1)0.5g,加入100mL甲醇溶液,于80℃溶解,过滤,滤液放冷结晶,过滤得晶体,用20mL去离子水洗涤沉淀3次,于60℃烘干得纯度高的槲皮素。(5) Recrystallization of quercetin: Take about 1.0 g of the crude quercetin prepared in step (4), add 100 mL of petroleum ether and 20 mL of deionized water, heat and stir at 80°C for 30 min, filter while hot, and deionize with 20 mL of deionized water Wash the precipitate with water for 3 times, dry at 60°C to obtain quercetin; weigh 0.5g of quercetin (1), add 100mL methanol solution, dissolve at 80°C, filter, let the filtrate cool to crystallize, filter to obtain crystals, and use 20mL The precipitate was washed three times with deionized water, and dried at 60°C to obtain quercetin with high purity.
与现有技术相比,本发明的有益效果为:Compared with prior art, the beneficial effect of the present invention is:
本发明所述方法操作简单,有机溶剂消耗少,生产成本低,工艺稳定,能耗小,污染少,所得产品纯度高,可适用于实验室和工业化制备。通过槲皮素纯度的检测:通过灼烧残渣检查、澄清度的检测和高效液相色谱检测对分离得到的槲皮素进行纯度检测,结果表明分离得到的槲皮素纯度>98%。The method of the invention has the advantages of simple operation, less consumption of organic solvent, low production cost, stable process, low energy consumption, less pollution and high purity of the obtained product, which is suitable for laboratory and industrial preparation. Through the detection of the purity of quercetin: the purity of the isolated quercetin was detected by the inspection of the residue on ignition, the detection of clarity and the detection of high performance liquid chromatography, and the results showed that the purity of the isolated quercetin was >98%.
附图说明Description of drawings
图1是槲皮素HPLC图。Figure 1 is the HPLC chart of quercetin.
具体实施方式Detailed ways
下面结合附图和具体实施例对本发明的技术方案作进一步详细地说明The technical solution of the present invention will be described in further detail below in conjunction with the accompanying drawings and specific embodiments
小花棘豆提取试验:Oxytropis floret extract test:
为了综合考察小花棘豆黄酮提取的影响因素,利用正交法“均衡分散”的特点,选取超声时间、甲醇浓度、物料比作为考察因素,并结合多次提取的经验每因素又选取3个水平安排试验,以黄酮的得率为衡量提取效率的客观指标,优选最佳提取工艺。In order to comprehensively investigate the influencing factors of the extraction of Oxytropis flavonoids, using the characteristics of "equilibrium dispersion" of the orthogonal method, ultrasonic time, methanol concentration, and material ratio were selected as the investigation factors, and combined with the experience of multiple extractions, three levels were selected for each factor Arrange experiments, take the yield of flavonoids as an objective index to measure the extraction efficiency, and optimize the best extraction process.
表1 正交试验设计Table 1 Orthogonal experimental design
表2 小花棘豆黄酮提取试验结果Table 2 Extraction test results of Oxytropis flavonoids
根据正交试验中结果最大的K值选出各因素中的最佳水平为:甲醇浓度100%,超声时间90min,料液比1:15。According to the largest K value in the orthogonal test, the best level of each factor is selected: the concentration of methanol is 100%, the ultrasonic time is 90min, and the ratio of solid to liquid is 1:15.
在一定温度、pH下,小花棘豆提取液以一定的流速通过树脂层析柱,测定流出液中总黄酮组分的含量;分别对上样液流速、温度、pH进行单因素试验,确定最佳吸附工艺条件。At a certain temperature and pH, the extract of Oxytropis florida passes through the resin chromatography column at a certain flow rate, and the content of the total flavonoids in the effluent is measured; the flow rate, temperature, and pH of the sample solution are subjected to single-factor experiments to determine the optimum Optimum adsorption process conditions.
表3 上样液pH值对大孔树脂吸附的影响Table 3 Effect of pH value of sample solution on adsorption of macroporous resin
表4 上样液温度对大孔树脂吸附的影响Table 4 The influence of sample solution temperature on the adsorption of macroporous resin
表5 上样液流速对大孔树脂吸附的影响Table 5 The effect of sample flow rate on the adsorption of macroporous resin
根据单因素试验结果,并尽可能的缩短试验时间,确定的最佳吸附工艺条件为:pH值4.0,温度室温,流速1.0BV/h。According to the single factor test results, and shorten the test time as much as possible, the optimum adsorption process conditions are determined as follows: pH value 4.0, temperature room temperature, flow rate 1.0BV/h.
槲皮素的制备需要较为激烈的水解条件,然而条件控制不当又极易导致黄酮环的降解。分别对水解液体的组成、物料比、水解时间和温度四个主要因素分别进行单因子试验。The preparation of quercetin requires severe hydrolysis conditions, but improper control of the conditions can easily lead to the degradation of the flavonoid ring. Single factor experiments were carried out on the four main factors of hydrolysis liquid composition, material ratio, hydrolysis time and temperature.
表6 水解液组成对槲皮素纯度的影响Table 6 The influence of hydrolyzate composition on the purity of quercetin
表7 物料比对槲皮素纯度的影响Table 7 The influence of material ratio on the purity of quercetin
表8 水解温度对槲皮素纯度的影响Table 8 The influence of hydrolysis temperature on the purity of quercetin
表9 水解时间对槲皮素纯度的影响Table 9 The influence of hydrolysis time on the purity of quercetin
根据单因素试验结果和试验成本,最佳试验条件为:水解液组成V甲醇:V水:V盐酸=35:5:10,水解时间90min,料液比1:60g/mL;水解温度80℃。According to the single factor test results and test cost, the best test conditions are: hydrolyzate composition V methanol : V water : V hydrochloric acid = 35:5:10, hydrolysis time 90min, solid-liquid ratio 1:60g/mL; hydrolysis temperature 80℃ .
取槲皮素样品1.5g置于坩埚中,加硫酸1.0mL溶解,低温加热至硫酸挥干后,在550℃完全灰化,移置干燥器内,放冷至室温,精密称定后,即得。槲皮素灼烧渣为0.038%,符合卫生部药品检查标准(≤0.05%);将槲皮素样品配成2%的甲醇溶液,放置一周仍然澄清,再按氢氧化四丁基铵非水滴定法不融物检查方法检查,在氨溶液、水及无水乙醇皆澄清,皆符合要求;槲皮素HPLC色谱条件为:十八烷基硅烷键合胶硅胶为填充剂,流动相为乙腈-甲醇(90:10),流速1mL/min,检测波长226nm,柱温30℃;检测方法:精密称取槲皮素1.0mg,加入甲醇10mL使其充分溶解,然后用甲醇定容至25mL,HPLC进样量为10μL,采用归一化法测定样品纯度,结果其纯度>98%。Take 1.5g of quercetin sample and place it in a crucible, add 1.0mL of sulfuric acid to dissolve it, heat it at low temperature until the sulfuric acid evaporates to dryness, then completely ash it at 550°C, transfer it to a desiccator, let it cool to room temperature, and weigh it accurately. have to. The burning residue of quercetin is 0.038%, which meets the drug inspection standard of the Ministry of Health (≤0.05%); the quercetin sample is made into 2% methanol solution, and it is still clear after standing for a week. The non-melting substance inspection method of the fixed method is checked, and it is clarified in ammonia solution, water and absolute ethanol, and all meet the requirements; the HPLC chromatographic conditions of quercetin are: octadecylsilane bonded gel silica gel is used as a filler, and the mobile phase is acetonitrile- Methanol (90:10), flow rate 1mL/min, detection wavelength 226nm, column temperature 30°C; detection method: Accurately weigh 1.0mg of quercetin, add 10mL of methanol to fully dissolve it, then dilute to 25mL with methanol, perform HPLC The injection volume was 10 μL, and the purity of the sample was determined by the normalization method, and the result was that the purity was >98%.
一种小花棘豆中槲皮素黄酮的制备方法,包括以下步骤:精密称取粉碎好的小花棘豆草粉1000.00g5份,按照最佳提取工艺提取,步骤(3)-(5)的方法分离槲皮素,分别得到槲皮素结晶10.423mg、10.532mg、10.630mg、10.445mg、10.533mg;如图1所示,按照HPLC方法检测,发现槲皮素纯度分别为98.62%、99.01%、98.84%、98.40%、98.74%,平均纯度为98.72%,变异系数为2.63%。结果表明:该制备方法具有较好的精密性,提取得到的槲皮素纯度较高。A preparation method of quercetin flavonoids in Oxytropis florifolius, comprising the following steps: precisely weighing 5 parts of 1000.00 g of Oxytropis florifolius powder, and extracting according to the best extraction process, the method of steps (3)-(5) Quercetin was separated to obtain 10.423mg, 10.532mg, 10.630mg, 10.445mg, and 10.533mg of quercetin crystals respectively; as shown in Figure 1, the purity of quercetin was found to be 98.62%, 99.01%, 98.84%, 98.40%, 98.74%, the average purity is 98.72%, and the coefficient of variation is 2.63%. The results showed that the preparation method had better precision, and the extracted quercetin had higher purity.
以上所述,仅为本发明较佳的具体实施方式,本发明的保护范围不限于此,任何熟悉本技术领域的技术人员在本发明披露的技术范围内,可显而易见地得到的技术方案的简单变化或等效替换均落入本发明的保护范围内。The above is only a preferred specific embodiment of the present invention, and the scope of protection of the present invention is not limited thereto. Any person familiar with the technical field within the technical scope disclosed in the present invention can obviously obtain the simplicity of the technical solution. Changes or equivalent replacements all fall within the protection scope of the present invention.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310403867.7A CN103467425B (en) | 2013-08-31 | 2013-08-31 | A kind of method of separating meletin from glabrous crazyweed |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310403867.7A CN103467425B (en) | 2013-08-31 | 2013-08-31 | A kind of method of separating meletin from glabrous crazyweed |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103467425A true CN103467425A (en) | 2013-12-25 |
CN103467425B CN103467425B (en) | 2016-04-27 |
Family
ID=49792503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310403867.7A Expired - Fee Related CN103467425B (en) | 2013-08-31 | 2013-08-31 | A kind of method of separating meletin from glabrous crazyweed |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103467425B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104068211A (en) * | 2014-06-14 | 2014-10-01 | 塔里木大学 | Preparation method and application of oxytropis glabra DC flavone |
CN104560399A (en) * | 2014-12-16 | 2015-04-29 | 湖北中烟工业有限责任公司 | A kind of purification method of jasmine flower extract for tobacco |
CN104774189A (en) * | 2015-03-31 | 2015-07-15 | 浙江大学 | Method for preparing high-purity quercetin |
CN107746398A (en) * | 2017-10-23 | 2018-03-02 | 苏州鑫旷新材料科技有限公司 | A kind of method for spending middle extraction Quercetin from sunflower |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999062480A2 (en) * | 1998-05-29 | 1999-12-09 | Parfums Christian Dior | Use of at least a cosmetically acceptable saponin or sapogenol as cosmetic agent for increasing the amount of collagen iv in the dermal-epidermal junction |
CN103202872A (en) * | 2013-04-08 | 2013-07-17 | 塔里木大学 | Preparation method and applications of flavonoid from Oxytropis glabra DC |
-
2013
- 2013-08-31 CN CN201310403867.7A patent/CN103467425B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999062480A2 (en) * | 1998-05-29 | 1999-12-09 | Parfums Christian Dior | Use of at least a cosmetically acceptable saponin or sapogenol as cosmetic agent for increasing the amount of collagen iv in the dermal-epidermal junction |
CN103202872A (en) * | 2013-04-08 | 2013-07-17 | 塔里木大学 | Preparation method and applications of flavonoid from Oxytropis glabra DC |
Non-Patent Citations (2)
Title |
---|
于荣敏 等: "小花棘豆中黄酮醇和黄酮醇甙的分离鉴定", 《中国中药杂志》 * |
于荣敏 等: "小花棘豆化学成分的研究", 《植物学报》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104068211A (en) * | 2014-06-14 | 2014-10-01 | 塔里木大学 | Preparation method and application of oxytropis glabra DC flavone |
CN104560399A (en) * | 2014-12-16 | 2015-04-29 | 湖北中烟工业有限责任公司 | A kind of purification method of jasmine flower extract for tobacco |
CN104560399B (en) * | 2014-12-16 | 2017-11-07 | 湖北中烟工业有限责任公司 | A kind of purification process of cigarette jasmine flower extract |
CN104774189A (en) * | 2015-03-31 | 2015-07-15 | 浙江大学 | Method for preparing high-purity quercetin |
CN107746398A (en) * | 2017-10-23 | 2018-03-02 | 苏州鑫旷新材料科技有限公司 | A kind of method for spending middle extraction Quercetin from sunflower |
Also Published As
Publication number | Publication date |
---|---|
CN103467425B (en) | 2016-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102526315B (en) | Preparation method of extracts of effective fractions of lychee seeds | |
CN102153534B (en) | Compound with tyrosinase inhibitory activity as well as preparation method and application thereof | |
CN104000892B (en) | A kind of method of extracting peony general flavone from peony | |
CN105820147B (en) | The preparation method and its usage of alpine yallow herb active component | |
CN103467425B (en) | A kind of method of separating meletin from glabrous crazyweed | |
CN102924421B (en) | Preparation method and application of compound having tyrosinase inhibitory activity | |
CN101297865A (en) | Method from extracting total flavones from guava leaves | |
CN105131062B (en) | A kind of preparation method of Baical Skullcap root P.E | |
CN101220013B (en) | Method for extracting and separating meletin from Mesona Procumbens Hemsl | |
CN103202872A (en) | Preparation method and applications of flavonoid from Oxytropis glabra DC | |
CN103342689B (en) | Method for separation and purification of luteolin, apigenin and diosmetin in trichosanthes peel | |
CN105106252A (en) | Method for extracting and separating flavonoid compounds from hypericum japonicum | |
CN102161649A (en) | Polyphenol type derivatives extracted from mulberry leaves and preparation method and applications thereof | |
CN104910172B (en) | Five kinds of talan trimer preparation methods and its application | |
CN100360551C (en) | Preparation of ursolic acid by acid-base method | |
CN102697838B (en) | Method for extracting and separating flavone enrichment substance, saponin enrichment substance and polysaccharide from astragalus simultaneously | |
JP2018502063A (en) | Method for extracting stilbene compounds | |
CN110960571A (en) | Preparation method of semen astragali complanati total flavonoids | |
CN105646638B (en) | The preparation method of pedunculoside | |
CN103113434A (en) | Method for preparing monoterpene glycoside from oil peony seed cake | |
CN110251552B (en) | A kind of preparation method of total flavonoids of A. | |
CN115010618A (en) | A kind of uric acid-lowering golden amide alcohol ester separation and purification method and application thereof | |
CN103239435B (en) | Preparation method of gynura divaricata total caffeoylquinic acid and application in antihyperglycemic agent or health-care product | |
CN103027909A (en) | Application of coumarins compounds and method for extracting coumarins compounds from winter daphne | |
CN102093380B (en) | Cyclic icaritin aglycon as well as preparation method and application of cyclic icaritin aglycon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160427 Termination date: 20160831 |